Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Stomach Ulcer
Interventions
DRUG

Rebamipide

"1. Brand name: Mucosta® Tab.~2. Generic name: Rebamipide.~3. Chemical name:~ (±)-2-(4-chlorobenzoylamino)-3-\[2(1H)-quinolinon-4-yl\]propionic acid.~4. Formulation: Tablet (White, film-coated tablet).~5. Strength: One tablet contains rebamipide 100mg.~6. Storage condition: 15℃\~25℃.~7. Manufacturer: Korea Otsuka Pharmaceuticals"

DRUG

Omeprazole

"1. Brand name: Losec® Cap.~2. Generic name: Omeprazole.~3. Chemical name:~5-melthoxy-2-{{{4-melthoxy-3.5-dlmethyl2-pyridinyl}methyl}sulp- hinyl}-1H-benzimidazole sodium. 4) Formulation: Capsule. 5) Strength: One capsule contains omeprazole 20mg. 6) Storage condition: 15℃\~25℃. 7) Manufacturer: AstraZenaca Korea."

Trial Locations (7)

200001

Ren-Ji Hospital - Shanghai Second Medical Univ., Shanghai

310003

The 1st Affiliated Hospital - Medical School of Zhejiang Univ., Hangzhou

510080

The 1st Affiliated hospital - Zhongshan Univ., Guangzhou

510515

Nanfang Hospital - Nanfang Medical Univ., Guangzhou

710032

Xijing Hospital - The 4th Military Medical Univ, Xi’an

425-707

Korea University Ansan Hospital, Ansan

120-752

Severance Hospital, Seoul National University, Seoul

Sponsors
All Listed Sponsors
collaborator

Zhejiang Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea Otsuka International Asia Arab

INDUSTRY